Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completed

The Effect of Body Mass Index In Relation To Menstrual Cycle Phase on Propofol Injection Pain

NCT04078087
completednot_applicable

Tracheal Intubation in Morbidly Obese (BMI>35) and in Lean (BMI<30) Patients Using McGrath MAC X-Blade

NCT03759990
completednot_applicable

NEFA (Non Esterified Fatty Acid) , Adipose Factors Behind Insulin Sensitivity

NCT01727245
completednot_applicable

In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man

NCT02889224

Clinical Trials (4)

Showing 4 of 4 trials
NCT04078087

The Effect of Body Mass Index In Relation To Menstrual Cycle Phase on Propofol Injection Pain

Completed
NCT03759990Not Applicable

Tracheal Intubation in Morbidly Obese (BMI>35) and in Lean (BMI<30) Patients Using McGrath MAC X-Blade

Completed
NCT01727245Not Applicable

NEFA (Non Esterified Fatty Acid) , Adipose Factors Behind Insulin Sensitivity

Completed
NCT02889224Not Applicable

In Vivo Study of Interactions Between the Endocannabinoid System and the Corticotropic Axis in Man

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4